Fonte: European Academy of Neurology. Unidade: FM
Assuntos: EPILEPSIA, WESTERN BLOTTING, HIPOCAMPO, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, N. C. et al. 5-hydroxytryptamine1A receptor density in the hippocampus ofpatients with temporal lobe epilepsy is associated with diseaseduration. European Academy of Neurology, v. 24, n. 4, p. 602-608, 2017Tradução . . Disponível em: https://doi.org/10.1111/ene.13252. Acesso em: 22 out. 2025.APA
Fonseca, N. C., Joaquim, H. P. G., Vicentiis, S., Gattaz, W. F., & Valente, K. D. (2017). 5-hydroxytryptamine1A receptor density in the hippocampus ofpatients with temporal lobe epilepsy is associated with diseaseduration. European Academy of Neurology, 24( 4), 602-608. doi:10.1111/ene.13252NLM
Fonseca NC, Joaquim HPG, Vicentiis S, Gattaz WF, Valente KD. 5-hydroxytryptamine1A receptor density in the hippocampus ofpatients with temporal lobe epilepsy is associated with diseaseduration [Internet]. European Academy of Neurology. 2017 ; 24( 4): 602-608.[citado 2025 out. 22 ] Available from: https://doi.org/10.1111/ene.13252Vancouver
Fonseca NC, Joaquim HPG, Vicentiis S, Gattaz WF, Valente KD. 5-hydroxytryptamine1A receptor density in the hippocampus ofpatients with temporal lobe epilepsy is associated with diseaseduration [Internet]. European Academy of Neurology. 2017 ; 24( 4): 602-608.[citado 2025 out. 22 ] Available from: https://doi.org/10.1111/ene.13252
